The FDA approved a new animal drug application in November 2015, concerning AquAdvantage Salmon, a genetically engineered Atlantic salmon. Documents related to this approval are available below. News FDA Releases Draft Amended Environmental Assessment for AquAdvantage Salmon and Announces Virtual Public Meeting Statement from FDA Commissioner Scott Gottlieb, M.D., on continued efforts to advance s